| LDR | 01245nam a22002891 4500 | ||
| 001 | 000029980 | ||
| 003 | MiAaHDL | ||
| 005 | 20241121000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 750416s1974 ne a 000 0 eng d | ||
| 020 | ⊔ | ⊔ | ‡a9021902826 |
| 035 | ⊔ | ⊔ | ‡a(MiU)990000299800106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990000299800106381 |
| 035 | ⊔ | ⊔ | ‡z(MiU)MIU01000000000000000029980-goog |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)1280558 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)159850361 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG1280558-B |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000029980 |
| 040 | ⊔ | ⊔ | ‡cOClW-H ‡d*OCL* ‡dMiU ‡dCStRLIN |
| 245 | 0 | 4 | ‡aThe scientific evaluation of drug equivalency: ‡bproceedings of a colloquium, Washington, D.C., June 14, 1974 / ‡ceditor, Albert N. Brest. |
| 260 | ⊔ | ⊔ | ‡aAmsterdam : ‡bExcerpta Medica ; ‡aNew York : ‡bAmerican Elsevier Pub. Co., ‡c1974 |
| 300 | ⊔ | ⊔ | ‡avii, lll p. : ‡bill ; ‡c23 cm. |
| 490 | 0 | ⊔ | ‡aInternational congress series ; no. 342 |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 2 | ‡aDrug Industry ‡xcongresses. |
| 650 | ⊔ | 0 | ‡aDrugs ‡xTesting ‡xCongresses. |
| 650 | ⊔ | 0 | ‡aBiopharmaceutics ‡xCongresses. |
| 700 | 1 | ⊔ | ‡aBrest, Albert N., ‡d1928- ‡1http://viaf.org/viaf/108140020 ‡0http://id.loc.gov/authorities/names/n79126272 |
| 899 | ⊔ | ⊔ | ‡a39015003204800 |
| CID | ⊔ | ⊔ | ‡a000029980 |
| DAT | 0 | ⊔ | ‡a20241120050541.0 ‡b20241121000000.0 |
| DAT | 1 | ⊔ | ‡a20241122181804.0 ‡b2024-11-23T10:25:27Z |
| DAT | 2 | ⊔ | ‡a2023-06-27T17:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990000299800106381 ‡aMiU ‡bSDR ‡cMIU ‡f000029980 ‡pmdp.39015003204800 ‡sMIU ‡1990000299800106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20241123 ‡sgoogle ‡umdp.39015003204800 ‡y1974 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929 |